Breast cancer cells secrete several growth factors, including receptor activators for nuclear factor-κB ligand (RANKL), which effectively promote osteoclast formation and activation, leading to excessive bone resorption (Blake et al., 2014; Bellanger et al., 2017). The gene discussed is TNFSF11; the disease is breast carcinoma.